Evaluation of Microbial Risk Factors in Relation to Clinical Effectiveness of Off-Label Bevacizumab Use for Retinal Disease Treatment: Research Article. Pak Euro. J. Med & LS [Internet]. 2026 Mar. 31 [cited 2026 May 2];9(1):25-34. Available from: https://readersinsight.net/index.php/PJMLS/article/view/3417